CRISPR Therapeutics AG Financial Statements 2014-2024 | CRSP
Format: Annual
Loading...
Annual Data | Millions of US $ except per share data
2024-12-31
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
2018-12-31
2017-12-31
2016-12-31
2015-12-31
Cost Of Goods Sold
-
-
-
-
-
-
-
-
-
-
$320.653
$387.332
$461.645
$340.567
$266.946
$179.362
$113.773
$69.8
$42.238
$12.573
Operating Expenses
-
-
-
-
-
-
-
-
-
-
$103.901
$71.816
$22.661
$6.003
$6.379
$20.566
$-5.485
$-1.96
$45.412
$-0.092
$-366.252
$-153.61
$-650.175
$377.661
$-348.865
$66.858
$-164.981
$-68.357
$-23.202
$-25.828
Other Income
-
-
-
-
-
-
-
-
-
-
$-366.252
$-153.61
$-650.175
$377.661
$-348.865
$66.858
$-164.981
$-68.357
$-23.202
$-25.828
Income From Discontinued Operations
-
-
-
-
-
-
-
-
-
-